Cargando…

Randomized trial of add‐on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy

OBJECTIVE: To investigate the feasibility, safety, and tolerability of add‐on treatment of the triglycerides of heptanoate (triheptanoin) vs the triglycerides of octanoate and decanoate (medium chain triglycerides [MCTs]) in adults with treatment‐refractory epilepsy. METHODS: After an 8‐week prospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borges, Karin, Kaul, Neha, Germaine, Jack, Kwan, Patrick, O'Brien, Terence J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398112/ https://www.ncbi.nlm.nih.gov/pubmed/30868125 http://dx.doi.org/10.1002/epi4.12308

Ejemplares similares

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Triheptanoin: First Approval
por: Shirley, Matt
Publicado: (2020)

Correction to: Triheptanoin: First Approval
por: Shirley, Matt
Publicado: (2020)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Cathodal transcranial direct‐current stimulation for treatment of drug‐resistant temporal lobe epilepsy: A pilot randomized controlled trial
por: Zoghi, Maryam, et al.
Publicado: (2016)

Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies
por: Han, Felicity Y., et al.
Publicado: (2021)

No effect of triheptanoin on exercise performance in McArdle disease
por: Madsen, Karen L., et al.
Publicado: (2019)

A randomized, double‐blind trial of triheptanoin for drug‐resistant epilepsy in glucose transporter 1 deficiency syndrome
por: Striano, Pasquale, et al.
Publicado: (2022)

Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Tefera, Tesfaye W., et al.
Publicado: (2016)

Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
por: Suh, Guk-Hee, et al.
Publicado: (2009)

Modified low ratio ketogenic therapy in the treatment of adults with super‐refractory status epilepticus
por: Kaul, Neha, et al.
Publicado: (2022)

The yield of long‐term electrocardiographic recordings in refractory focal epilepsy
por: van der Lende, Marije, et al.
Publicado: (2019)

Medium Chain Triglycerides
por: Sribney, Michael
Publicado: (1968)

The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders
por: Lee, Sun Ku, et al.
Publicado: (2021)

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study
por: Wechsler, Robert T, et al.
Publicado: (2014)

Long‐term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11‐year, open‐label, follow‐up trial
por: O’Brien, Terence J., et al.
Publicado: (2020)

The Effects of a Ketogenic Medium-Chain Triglyceride Diet on the Feces in Dogs With Idiopathic Epilepsy
por: Pilla, Rachel, et al.
Publicado: (2020)

Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
por: Mochel, Fanny, et al.
Publicado: (2016)

Exploring triheptanoin as treatment for short chain enoyl CoA hydratase deficiency
por: Engelstad, Kristin, et al.
Publicado: (2021)

Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
por: Kriechbaumer, Sandra R. P., et al.
Publicado: (2022)

Headaches add to the burden of epilepsy
por: Syvertsen, Marte, et al.
Publicado: (2007)

A multicenter randomized controlled trial of medium‐chain triglyceride dietary supplementation on epilepsy in dogs
por: Berk, Benjamin A., et al.
Publicado: (2020)

Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia
por: Szefel, Jarosław, et al.
Publicado: (2016)

A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood
por: Hainque, Elodie, et al.
Publicado: (2017)

Triheptanoin – Novel therapeutic approach for the ultra-rare disease mitochondrial malate dehydrogenase deficiency
por: Laemmle, Alexander, et al.
Publicado: (2021)

Preferences of young adults on the development of a new digital add-on alcohol intervention for depression treatment: A qualitative study
por: Schouten, Maria J.E., et al.
Publicado: (2023)

The utility of an automated and ambulatory device for detecting and differentiating epileptic and psychogenic non‐epileptic seizures
por: Naganur, Vaidehi D., et al.
Publicado: (2019)

Metabolic fingerprinting of dogs with idiopathic epilepsy receiving a ketogenic medium-chain triglyceride (MCT) oil
por: Berk, Benjamin Andreas, et al.
Publicado: (2022)

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)
por: Rudà, Roberta, et al.
Publicado: (2020)

Seven tesla MRI improves detection of focal cortical dysplasia in patients with refractory focal epilepsy
por: Veersema, Tim J., et al.
Publicado: (2017)

Medium-chain Triglyceride Ketogenic Diet as a Treatment Strategy for Adult Super-refractory Status Epilepticus
por: Dutta, Kaustuv, et al.
Publicado: (2022)

Efficacy of Lacosamide Add-on Therapy on Refractory Focal Epilepsies in Children and Adolescents: An Open-Label Clinical Trial
por: Mohammadi, Tayebeh, et al.
Publicado: (2023)

Low- vs High-Frequency Repetitive Transcranial Magnetic Stimulation as an Add-On Treatment for Refractory Depression
por: Eche, Julien, et al.
Publicado: (2012)

Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
por: Sklirou, Evgenia, et al.
Publicado: (2021)

Combination of triheptanoin with the ketogenic diet in Glucose transporter type 1 deficiency (G1D)
por: Avila, Adrian, et al.
Publicado: (2023)

Applications of Medium-Chain Triglycerides in Foods
por: Watanabe, Shinji, et al.
Publicado: (2022)

Applications for Deep Learning in Epilepsy Genetic Research
por: Zeibich, Robert, et al.
Publicado: (2023)

K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy
por: Schoeler, Natasha E, et al.
Publicado: (2021)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy
por: Silvennoinen, Katri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q854v0mvjpvs3lvg8367on3tjp